MSB 3.50% $1.33 mesoblast limited

Wise heads needto prevail, page-103

  1. 17,021 Posts.
    lightbulb Created with Sketch. 8451
    In the meantime he is talking to a number of partners to pick up where TEVA left off with the proviso that they will go all the way with commercialization and marketing.

    For more than half a decade there has been talk of partners.
    And for more than half a decade none have eventuated.

    What's changed (other than one of MSB's major sources of credentialisation has, as of today, ridden off into the sunset and other than MSB's bargaining position currently being in the weakest position it has ever been)?


    "Surely Teva would have been circled by a few majors for these assets."

    @Invest Egate ,

    If that's the case how come Teva didn't simply on-sell the CHF program to them for a few hundred million dollars? Or a few tens of millions of dollars? Or just a few million dollars, even?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.33
Change
0.045(3.50%)
Mkt cap ! $1.518B
Open High Low Value Volume
$1.30 $1.35 $1.30 $2.885M 2.183M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 7070 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.